Recently, there has been a lot of talk about molecular diagnostics in the context of cancer. What are the most important needs in this area when it comes to lung cancer patients? We ask Aleksandra Wilk, director of the Lung Cancer Section of the TO SIĘ LECZY Foundation, about this.
Aleksandra Wilk:
- Medicine is advancing, newer therapies are being developed for patients with lung cancer and other cancers.
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
